A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee

Clinical trial NCT00240773 · COMPLETED

Trial details

NCT number: NCT00240773
Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis, Hip Osteoarthritis, Knee

Enrollment: 581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.